3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
1
Interventions
Standard of Care
4
Radiotherapy
4
Oxaliplatin
4
tislelizumab
3
anlotinib
2
Radiation
2
Paclitaxel
2
Capecitabine
2
130-nm albumin-bound paclitaxel
2
vedolizumab
1
trastuzumab deruxtecan
1
trametinib
1
toripalimab
1
surufatinib
1
pembrolizumab
1
ivosidenib
1
disitamab vedotin
1
coenzyme Q10
1
cemiplimab
1
blinatumomab
1
Whole Genome Sequencing
1
Ursodeoxycholic Acid
1
Ultrasonography
1
Tretinoin
1
Thymopentin
1
Surgical Procedures, Operative
1
Sequence Analysis, RNA
1
Respiratory Rate
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Aquatic Therapy
×
Tumor-Agnostic
×
Clear all
NCT05980325
2024-12-06
EFFORT
Universitat Pompeu Fabra
Phase NA
Not yet recruiting
45 enrolled